Pioglitazone was the most effective medication, evidenced by the most reduction in GGT, ALT, AST, lobular inflammation fibrosis, and steatosis (effectiveness = 82% reduction in NAS, estimated effect difference median of −1.50 (95% Cl −2.08, −1.00). The gene discussed is GPT; the disease is steatosis.